Concepedia

Jan Alvar Lindencrona

JA

5

Publications

234

Citations

5

H-Index

2001

Active since

Affiliations

Karolinska Institutet(Current)

Jan Alvar Lindencrona is an author at Karolinska Institutet specializing in medicine, cross-protection, and vaccine development.

Top concepts

Publications per year

2001–2005

5

Publications

5

A Single Vaccination with Polyomavirus VP1/VP2Her2 Virus-Like Particles Prevents Outgrowth of HER-2/<i>neu</i>–Expressing Tumors

Karin Tegerstedt, Jan Alvar Lindencrona, Claudia Curcio et al. · Cancer Research · 2005 · 76 citations

CD4<sup>+</sup> T cell‐mediated HER‐2/neu‐specific tumor rejection in the absence of B cells

Jan Alvar Lindencrona, Thomas Kammertoens, Thomas Schüler et al. · International Journal of Cancer · 2003 · 52 citations · Full text

Protective Efficacy of a DNA Influenza Virus Vaccine Is Markedly Increased by the Coadministration of a Schiff Base-Forming Drug

Jehad Charo, Jan Alvar Lindencrona, Lena-Maria Carlson et al. · Journal of Virology · 2004 · 46 citations · Full text

, , +15

Improved Immunogenicity of an Immunodominant Epitope of the Her-2/neu Protooncogene by Alterations of MHC Contact Residues

Simona Vertuani, Alessandro Sette, John Sidney et al. · The Journal of Immunology · 2004 · 36 citations

Enhancing T Cell Activation and Antiviral Protection by Introducing the HIV-1 Protein Transduction Domain into a DNA Vaccine

Jens A. Leifert, Jan Alvar Lindencrona, Jehad Charo et al. · Human Gene Therapy · 2001 · 24 citations

Rows per page

1–5 of 5